SIC
BMY icon

Shoker Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Shoker Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Sell
8,538
-96
-1% -$5.6K 0.15% 76
2025
Q4 		$466K Buy
8,634
+546
+7% +$26.3K 0.14% 79
2025
Q3 		$365K Buy
8,088
+178
+2% +$8.31K 0.11% 91
2025
Q2 		$366K Buy
+7,910
New +$388K 0.11% 88

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shoker Investment Counsel's BMY Position: Q1 2026 in Review

Shoker Investment Counsel reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2026, selling an estimated $5.6K and leaving 8,538 shares worth $518K. The position accounts for 0.15% of the portfolio, ranked #76.

Shoker Investment Counsel first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Shoker Investment Counsel held 8,538 shares of Bristol-Myers Squibb worth $518K as of Q1 2026.
  • Shoker Investment Counsel sold 96 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.6K.
  • Bristol-Myers Squibb made up 0.15% of Shoker Investment Counsel's portfolio in Q1 2026, its #76 holding.
  • Shoker Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Shoker Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.